Further Information:
The Health Products Regulatory Authority has been notified of a shortage of the following products:
- Amorolfine 5%w/v Medicated Nail Lacquer - PA0711/309/001
- Caverject 20mcg Powder and Solvent for Solution for Injection - PA0822/115/003
- Clopidogrel 75mg Film-Coated Tablets - PA2315/198/001
- Dukoral - EU/1/03/263/002
- Keflex 500mg Film Coated Tablets - PA1226/002/004
- Keflex 125mg/5ml Powder for Oral Suspension - PA1226/002/002
- Lasix 20mg/2ml Solution for Injection or Infusion - PA0540/052/002
- Nu-seals 300mg Gastro-Resistant Tablets - PA2325/010/002
- OxyContin 10mg Prolonged Release Tablets - PA1688/005/002
- Provigil 100mg Tablets - PA0749/198/001
- Provigil 200mg Tablets - PA0749/198/002
- Subutex 8mg Sublingual Tablets - PA22617/001/003
- Tradol 50mg Effervescent Tablets - PA0074/094/001
- Warfant 1mg Tablets - PA0073/139/001
The following shortages have been resolved and supply has resumed to the Irish market:
- Acetylcysteine Essential-Healthcare 600mg Effervescent Tablets - PA2130/002/001
- CellCept 500mg Powder for Concentrate for Solution for Infusion - EU/1/96/005/005
- Creon 25000 Gastro Resistant Capsules - PA2010/008/002
- Creon 10000 Gastro Resistant Capsules - PA2010/008/003
- Epilim Chronosphere 500mg Prolonged Release Granules- PA0540/150/007
- Estradot 75mcg/24 hours, Transdermal Patch - PA0896/010/003
- Fentanyl 100mcg in 2ml Solution for Injection - PA0073/122/001
- Fexofenadine Hydrochloride 120mg Film Coated Tablets - PA22871/004/002
- Gerax 250mcg Tablets - PA1445/024/001
- Lyrica 25mg Hard Capsule - EU/1/04/279/003
- Rifater 50mg/300mg/120mg Tablets - PA0540/067/001
- Taxotere 20mg/1ml Concentrate for Solution for Infusion - EU/1/95/002/00
- Tradol 50mg Hard Capsules - PA0711/029/001
- Tramadol hydrochloride 50mg Hard Capsules - PA2315/214/001
- Tramadol Krka 50mg Hard Capsules - PA1347/079/001
- Trileptal 300mg Film Coated Tablets - PA0896/033/002
Please see the shortages section of the HPRA website for further information
The HPRA sends weekly updates concerning medicinal product shortages. However, the above webpage will be updated as new information is provided to the HPRA.